These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 27436172)
1. Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites. Willavize S; Fiedler-Kelly J; Ludwig E; Guan L J Clin Pharmacol; 2017 Feb; 57(2):255-265. PubMed ID: 27436172 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies. Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P Clin Drug Investig; 2009; 29(2):87-100. PubMed ID: 19133704 [TBL] [Abstract][Full Text] [Related]
3. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study. Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P Drugs Aging; 2011 Feb; 28(2):139-50. PubMed ID: 21275439 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of modafinil and its acid and sulfone metabolites in Chinese males. Seng KY; Fan L; Lee HS; Yong WP; Goh BC; Lee LS Ther Drug Monit; 2011 Dec; 33(6):719-29. PubMed ID: 22105589 [TBL] [Abstract][Full Text] [Related]
5. Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies. Darwish M; Kirby M; Hellriegel ET; Robertson P Clin Drug Investig; 2009; 29(9):613-23. PubMed ID: 19663523 [TBL] [Abstract][Full Text] [Related]
6. Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers. Wong YN; King SP; Laughton WB; McCormick GC; Grebow PE J Clin Pharmacol; 1998 Mar; 38(3):276-82. PubMed ID: 9549666 [TBL] [Abstract][Full Text] [Related]
7. Comparison of steady-state plasma concentrations of armodafinil and modafinil late in the day following morning administration: post hoc analysis of two randomized, double-blind, placebo-controlled, multiple-dose studies in healthy male subjects. Darwish M; Kirby M; Hellriegel ET Clin Drug Investig; 2009; 29(9):601-12. PubMed ID: 19663522 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression. Niemegeers P; Maudens KE; Morrens M; Patteet L; Joos L; Neels H; Sabbe BG Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1189-97. PubMed ID: 22803602 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of potential pharmacokinetic drug-drug interaction between armodafinil and risperidone in healthy adults. Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P Clin Drug Investig; 2015 Nov; 35(11):725-33. PubMed ID: 26387027 [TBL] [Abstract][Full Text] [Related]
10. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships. Darwish M; Bond M; Ezzet F J Clin Pharmacol; 2012 Sep; 52(9):1328-42. PubMed ID: 22039290 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. Wong YN; Simcoe D; Hartman LN; Laughton WB; King SP; McCormick GC; Grebow PE J Clin Pharmacol; 1999 Jan; 39(1):30-40. PubMed ID: 9987698 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Dinges DF; Arora S; Darwish M; Niebler GE Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442 [TBL] [Abstract][Full Text] [Related]
13. Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. Wong YN; King SP; Simcoe D; Gorman S; Laughton W; McCormick GC; Grebow P J Clin Pharmacol; 1999 Mar; 39(3):281-8. PubMed ID: 10073328 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. Darwish M; Kirby M; D'Andrea DM; Yang R; Hellriegel ET; Robertson P Clin Ther; 2010 Nov; 32(12):2074-87. PubMed ID: 21118743 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the potential for a pharmacokinetic drug-drug interaction between armodafinil and ziprasidone in healthy adults. Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P Clin Drug Investig; 2014 Oct; 34(10):691-9. PubMed ID: 25047407 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tolerability of modafinil tablets in Chinese subjects. Xu P; Li HD; Zhang BK; Xiao YW; Yuan HY; Zhu YG J Clin Pharm Ther; 2008 Aug; 33(4):429-37. PubMed ID: 18613861 [TBL] [Abstract][Full Text] [Related]
17. Steady-state pharmacokinetics and tolerability of modafinil administered alone or in combination with dextroamphetamine in healthy volunteers. Hellriegel ET; Arora S; Nelson M; Robertson P J Clin Pharmacol; 2002 Apr; 42(4):450-60. PubMed ID: 11936571 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. Wong YN; Wang L; Hartman L; Simcoe D; Chen Y; Laughton W; Eldon R; Markland C; Grebow P J Clin Pharmacol; 1998 Oct; 38(10):971-8. PubMed ID: 9807980 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China. Wu KH; Guo T; Deng CH; Guan Z; Li L; Zhou TY; Lu W Acta Pharmacol Sin; 2012 Nov; 33(11):1401-8. PubMed ID: 23103618 [TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus. Wang K; Feng L; Zhang J; Zou Q; Xu F; Sun Z; Tang F; Chen L Clin Pharmacokinet; 2023 Oct; 62(10):1413-1425. PubMed ID: 37537410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]